Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase

Predicting prognosis and treatment response of breast cancer patients using expression and cellular localization of N-myristoyltransferase

US Patent 11885808 · Granted Jan 30, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-myristoyltransferase (NMT)1, NMT2 and methionine aminopeptidase 2 overexpressi2024
Methionine aminopeptidase overexpression in the peripheral blood and peripheral 2022
Use of N-myristoyltransferase on non-tumor tissue for cancer diagnosis2011